Shore ND, Nishiyama H, Redorta JP, Krawczynski M, et al. Durvalumab in Combination with Bacillus Calmette-Guerin Induction and Maintenance Therapy for Bacillus Calmette-Guerin-Naive, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum. J Urol 2026;216:607.
PMID: 42713893